Top 5 Strong Buy Stocks for June 4th

Five stocks have been added to the Zacks Rank #1 (Strong Buy) List today, including BioCryst Pharmaceuticals, OptimizeRx, Bridgewater Bancshares, Palomar Holdings, and Ferrari. The companies have seen significant increases in the Zacks Consensus Estimate for their earnings over the last 60 days.

Five stocks have been added to the Zacks Rank #1 (Strong Buy) List today, indicating significant potential for growth. These companies, BioCryst Pharmaceuticals (BCRX), OptimizeRx (OPRX), Bridgewater Bancshares (BWB), Palomar Holdings (PLMR), and Ferrari (RACE), have seen substantial increases in the Zacks Consensus Estimate for their earnings over the last 60 days.

BioCryst Pharmaceuticals, a leader in crystallography and structure-based drug design, has seen its earnings estimate increase by 83.3% over the last 60 days. This growth is driven by the company's innovative approach to developing novel therapeutics for various diseases. OptimizeRx, which provides platforms to help patients afford and comply with their medicines, has seen its earnings estimate increase by 27.5%. Bridgewater Bancshares, a provider of personal and commercial banking services, has seen its earnings estimate increase by 11.7%. Palomar Holdings, focused on catastrophe insurance, has seen its earnings estimate increase by 4.6%. Ferrari, known for its high-performance sports cars, has seen its earnings estimate increase by 4.4%.

These companies were handpicked by Zacks experts as potential home runs, with previous recommendations soaring by as much as +673.0%. Investors should consider these stocks for their growth potential, but it is essential to conduct thorough research and consider individual risk tolerance.

References:
[1] https://www.nasdaq.com/articles/new-strong-buy-stocks-june-4th-0
[2] https://www.globenewswire.com/news-release/2025/06/02/3091727/29446/en/BioCryst-to-Present-New-Data-at-2025-Meeting-of-the-European-Academy-of-Allergy-and-Clinical-Immunology.html